Investigating Stem Cell Transplantation as a Potential Option for Refractory Crohn’s Disease
Autologous stem cell transplantation (ASCT) is emerging as a potential treatment for patients with refractory Crohn’s disease (CD). A study presented at ECCO 2025 demonstrated promising clinical and endoscopic remission rates.
